Vectrus (VEC) shares soared 6.2% in the last trading session to close at $54.30. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the ...
On September 8, 2014, Exelis, Inc. (XLS, $18.13, Market Capitalization: $3.4 billion) announced that its board of directors approved the spin-off of Vectrus, Inc (VEC) and declared the details and ...
SillaJen and collaboration partner Transgene today separately acknowledged the failure of their lead pipeline candidate Pexa-Vec (pexastimogene devacirepvec) in a Phase III trial assessing a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results